32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
16 °P sammeln
  • Broschiertes Buch

Cancer is a second leading cause of death in the world. It has been a lot of research being done on cancer therapeutics but the deadliness of this disease has not been cured. This book insights into development of new avenue of synthetic compounds and their assessment in terms of effectiveness against major kinds of cancers i.e. lymphoma, breast cancer, and layrnx cancer along with safety study on kidney cells in vitro. In addition, it also describes number of assays available for screening. This can be useful to the students working on cancer research in chemistry, biochemistry as well as in…mehr

Produktbeschreibung
Cancer is a second leading cause of death in the world. It has been a lot of research being done on cancer therapeutics but the deadliness of this disease has not been cured. This book insights into development of new avenue of synthetic compounds and their assessment in terms of effectiveness against major kinds of cancers i.e. lymphoma, breast cancer, and layrnx cancer along with safety study on kidney cells in vitro. In addition, it also describes number of assays available for screening. This can be useful to the students working on cancer research in chemistry, biochemistry as well as in vitro cytotoxicity screening departments. Also this can be a guide to usher lights to the budding researchers on their pathways towards synthetic therapies for different types of cancer and related diseases.
Autorenporträt
Bhuvan P. Raval, M.Pharm, PGDPRA, MBA, FSAB, (Ph.D.) is an Asst. Professor at K. J. College of Pharmacy, Vadasma. He has more than 15 research publications and 28 presentations in international journals to his credit.He is engaged with no. of journals as an editor and has also delivered lectures at international conferences viz. MIPTEC, Switzerland